Acosta MI, Urbach S, Doye A, Ng YW, Boudeau J, Mettouchi A, Debant A et al (2018) Group-I PAKs-mediated phosphorylation of HACE1 at serine 385 regulates its oligomerization state and Rac1 ubiquitination. Sci Rep 8:1410
Article PubMed PubMed Central Google Scholar
Bae AN, Jung SJ, Lee JH, Lee H, Park SG (2022) Clinical value of EZH2 in hepatocellular carcinoma and its potential for target therapy. Medicina (kaunas). https://doi.org/10.3390/medicina58020155
Cao W, Lee H, Wu W, Zaman A, McCorkle S, Yan M, Chen J et al (2020) Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma. Nat Commun 11:3675
Article CAS PubMed PubMed Central Google Scholar
Cassetta L, Pollard JW (2020) Tumor-associated macrophages. Curr Biol 30:R246–R248
Article CAS PubMed Google Scholar
Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA (2022) The complex role of tumor-infiltrating macrophages. Nat Immunol 23:1148–1156
Article CAS PubMed PubMed Central Google Scholar
Da C, Pu J, Liu Z, Wei J, Qu Y, Wu Y, Shi B et al (2021) HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells. Signal Transduct Target Ther 6:399
Article CAS PubMed PubMed Central Google Scholar
Dong N, Shi X, Wang S, Gao Y, Kuang Z, Xie Q, Li Y et al (2019) M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma. Br J Cancer 121:22–33
Article PubMed PubMed Central Google Scholar
Donne R, Lujambio A (2023) The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma. Hepatology 77:1773–1796
El-Naggar AM, Clarkson PW, Negri GL, Turgu B, Zhang F, Anglesio MS, Sorensen PH (2019) HACE1 is a potential tumor suppressor in osteosarcoma. Cell Death Dis 10:21
Article CAS PubMed PubMed Central Google Scholar
Eluard B, Thieblemont C, Baud V (2020) NF-kappaB in the new era of cancer therapy. Trends Cancer 6:677–687
Article CAS PubMed Google Scholar
Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314
García-Vilas JA, Medina M (2018) Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications. World J Gastroenterol 24:3695–3708
Article PubMed PubMed Central Google Scholar
Hao A, Wang Y, Stovall DB, Wang Y, Sui G (2021) Emerging roles of LncRNAs in the EZH2-regulated oncogenic network. Int J Biol Sci 17:3268–3280
Article CAS PubMed PubMed Central Google Scholar
Ju X, Zhang H, Zhou Z, Chen M, Wang Q (2020) Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-a signaling. Exp Cell Res 396:112315
Article CAS PubMed Google Scholar
Kimura M, Moteki H, Ogihara M (2023) Role of hepatocyte growth regulators in liver regeneration. Cells. https://doi.org/10.3390/cells12020208
Article PubMed PubMed Central Google Scholar
Kogler M, Tortola L, Negri GL, Leopoldi A, El-Naggar AM, Mereiter S, Gomez-Diaz C et al (2020) HACE1 prevents lung carcinogenesis via inhibition of RAC-Family GTPases. Cancer Res 80:3009–3022
Article CAS PubMed PubMed Central Google Scholar
Kulik L, El-Serag HB (2019) Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156:477–491
Li JC, Chang X, Chen Y, Li XZ, Zhang XL, Yang SM, Hu CJ et al (2019) Loss of the tumor suppressor HACE1 contributes to cancer progression. Curr Drug Targets 20:1018–1028
Article CAS PubMed Google Scholar
Li C, Xu X, Wei S, Jiang P, Xue L, Wang J, Senior C (2021) Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J Immunother Cancer. https://doi.org/10.1136/jitc-2020-001341
Article PubMed PubMed Central Google Scholar
Lin W, Zhou Q, Wang CQ, Zhu L, Bi C, Zhang S, Wang X et al (2020) LncRNAs regulate metabolism in cancer. Int J Biol Sci 16:1194–1206
Article CAS PubMed PubMed Central Google Scholar
Liu Z, Suo C, Mao X, Jiang Y, Jin L, Zhang T, Chen X (2020) Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990–2017. Cancer 126:2267–2278
Pan Y, Yu Y, Wang X, Zhang T (2020) Tumor-associated macrophages in tumor immunity. Front Immunol 11:583084
Article CAS PubMed PubMed Central Google Scholar
Park EG, Pyo SJ, Cui Y, Yoon SH, Nam JW (2022) Tumor immune microenvironment lncRNAs. Brief Bioinform. https://doi.org/10.1093/bib/bbab504
Article PubMed PubMed Central Google Scholar
Pothula SP, Xu Z, Goldstein D, Pirola RC, Wilson JS, Apte MV (2020) Targeting HGF/c-MET axis in pancreatic cancer. Int J Mol Sci. https://doi.org/10.3390/ijms21239170
Article PubMed PubMed Central Google Scholar
Qi J, Chen X, Wu Q, Wang J, Zhang H, Mao A, Zhu M et al (2020) Fasting induces hepatocellular carcinoma cell apoptosis by inhibiting set8 expression. Oxid Med Cell Longev 2020:3985089
Article PubMed PubMed Central Google Scholar
Rao X, Zhou X, Wang G, Jie X, Xing B, Xu Y, Chen Y et al (2022) NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer. Cell Death Dis 13:891
Article CAS PubMed PubMed Central Google Scholar
Reid S, Fine N, Bhosle VK, Zhou J, John R, Glogauer M, Robinson LA et al (2020) Inhibition of BRD4 Reduces Neutrophil Activation and Adhesion to the Vascular Endothelium Following Ischemia Reperfusion Injury. Int J Mol Sci. https://doi.org/10.3390/ijms21249620
Article PubMed PubMed Central Google Scholar
Ren C, Han X, Lu C, Yang T, Qiao P, Sun Y, Yu Z (2022) Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance. Cell Death Differ 29:381–392
Article CAS PubMed Google Scholar
Sakata M, Yokomizo K, Kitamura Y, Sakuraba K, Shirahata A, Goto T, Mizukami H et al (2013) Methylation of the HACE1 gene is frequently detected in hepatocellular carcinoma. Hepatogastroenterology 60:781–783
Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33
Sun L, Su Y, Liu X, Xu M, Chen X, Zhu Y, Guo Z et al (2018) Serum and exosome long non coding RNAs as potential biomarkers for hepatocellu
留言 (0)